HIGH
Wealth Inequality Second Phase — When the Middle Class Disappears. K-shaped economy, asset owners vs wage earners, intergenerational transfer. Historical precedents and evidence-based solutions.
Week of 23 Mar
HIGH
The Housing Crisis — A Global Structural Failure. Why housing unaffordable for young people worldwide. Zoning, NIMBYism, financialisation. What Vienna, Singapore, Tokyo actually solved and how.
Week of 23 Mar
HIGH
Dollar Dependency — What Happens If It Ends. Why dollar reserve status has been invisible subsidy of American living standards. De-dollarisation: how fast, what consequences for ordinary savers.
Week of 23 Mar
HIGH
Critical Minerals — The New Oil. China controls 70%+ of global rare earth refining and 90%+ of high-performance magnet production. April 2025 Beijing weaponized this: export controls on 7 heavy rare earth elements. Ford Chicago factory shut. EV and defense supply chains seized globally. Why diversification is measured in decades not years. The US $400M bet on MP Materials. The Kuala Lumpur Accord. The misinformation: that Western nations can mine their way out of Chinese processing dominance within any near-term horizon.
Week of 23 Mar
HIGH
The Sovereign Debt Reckoning — The Crisis That Is Already Here. Global public debt projected to exceed 100% of GDP by 2029 — highest since 1948. Developing nations paying record $400B in external debt service annually. 15 sovereign defaults 2020-2023. IMF Common Framework too slow. 42% of global sovereign debt matures by 2027, issued at near-zero rates now refinancing at 4-6%. The misinformation: that this is only a problem for poorly-governed poor countries. France, the UK, and the US face their own version.
Week of 23 Mar
HIGH
The Price of Residency — What Countries Actually Charge Foreigners to Stay, and Why. Golden visas, digital nomad permits, investor residency, skilled worker cards, retirement visas, dependent permits — the real costs, hidden fees, and renewal traps. Country-by-country comparison: Japan, France, UK, USA, UAE, Thailand, Portugal, Malaysia, Singapore, Canada, Germany. Who each programme actually targets vs who it claims to target. Labour market reality: which countries genuinely need workers vs which sell residency as revenue extraction. Tax obligations for residents vs non-residents, dependents, retirees. Social integration requirements vs paper exercises. What is changing now: EU golden visa crackdowns, Japan loosening immigration, Gulf states competing for talent. The gap between immigration policy rhetoric and economic reality. Origin-country disparities: same qualifications, vastly different treatment depending on passport. The misinformation: that these programmes are designed to attract the best — many are designed to extract maximum fees from the most desperate.
Week of 30 Mar
HIGH
The Seed Oil Panic — What the Science Actually Says. Canola, sunflower, soybean — the internet says they are poison. Omega-6 ratio arguments, inflammatory markers, oxidation during cooking. What peer-reviewed research actually shows vs influencer claims. Historical context: how seed oils replaced animal fats and why. Japan, Mediterranean, Nordic diets — all use different oils with different outcomes. The dose-response evidence. Industry funding on both sides. What a cardiologist would tell you vs what a TikTok carnivore tells you.
Week of 30 Mar
HIGH
Why Is Everything So Expensive? — The Actual Breakdown. Inflation cooled but prices never came back down. Shrinkflation, greedflation, supply chain restructuring. Where the money actually goes: housing, food, insurance, energy, childcare. Country-by-country comparison: USA, UK, France, Japan, Germany, Australia, Canada. Real wage purchasing power vs 2019 baseline. Corporate profit margins during and after inflation. What economists agree on, what they dispute, and what nobody wants to say. The compounding effect on people under 35.
Week of 30 Mar
HIGH
Supplements That Work vs Supplements That Are Expensive Urine. The supplement industry: \80 billion globally, largely unregulated in most countries. Evidence-tier grading of the top 30 supplements: Vitamin D, omega-3, magnesium, zinc, creatine, probiotics, collagen, turmeric/curcumin, ashwagandha, B12, iron, melatonin, CoQ10, NAC, berberine, L-theanine, lions mane, vitamin C megadose, multivitamins, protein powder, BCAAs, glutamine, CLA, apple cider vinegar pills, elderberry, echinacea, biotin, glucosamine, milk thistle, saw palmetto. For each: what clinical trials show, who actually benefits (deficiency vs general population), optimal dosing, bioavailability issues, dangerous interactions. The industry tricks: proprietary blends hiding underdosing, citing rat studies as human evidence, influencer kickback economics. What doctors actually take themselves.
Week of 30 Mar
HIGH
What \00 Gets You in Healthcare: USA vs France vs Japan vs Thailand vs UK vs Germany vs India vs Brazil. Same medical needs, radically different costs. Breakdown by: GP visit, specialist consultation, blood panel, MRI scan, dental filling, ER visit, one night hospitalisation, prescription (insulin, antibiotics, antidepressants), childbirth, appendectomy. How each system works: insurance-based, single-payer, out-of-pocket, hybrid. Hidden costs: deductibles, co-pays, waiting time as economic cost, medical tourism as market signal. Quality outcomes vs cost: infant mortality, life expectancy, cancer survival, access speed. Who falls through the cracks in each system. The pharmaceutical price gap: same drug, same manufacturer, 10x price difference between countries.
Week of 30 Mar